SCHEMBL25958598

SCHEMBL25958598

Cc1ccc(NC(=O)c2nn(S(C)(=O)=O)c(Cl)c2Br)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
LMNA P02545 5/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
FLT1 P17948 2/20 0.40
KDR P35968 2/20 0.40
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
GAA P10253 3/20 0.37
HPGD P15428 2/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25958613 0.91 L3MBTL1 (0.45) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL22257175 0.90 RAB9A (0.53) L3MBTL1NPC1RAB9ALMNAKMT2A
SCHEMBL25958608 0.89 FLT1 (0.41) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL25958595 0.89 LMNA (0.43) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL25958590 0.89 POLB (0.47) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL25958294 0.84 L3MBTL1 (0.45) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL25958272 0.84 NPC1 (0.42) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL22257180 0.83 ALOX15 (0.56) NPC1RAB9ALMNAKMT2AMAPT
SCHEMBL25958241 0.81 L3MBTL1 (0.44) L3MBTL1NPC1RAB9ALMNANFKB1
SCHEMBL22257181 0.81 NPC1 (0.45) NPC1RAB9ASMN1; SMN2KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2023-08-10 US disclosed
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same EMPIRICO INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B L3MBTL1 2134/4885NPC1 2279/4885RAB9A 4106/4885
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same ALOX15, ALOX5, ALOX15B L3MBTL1 2134/4885NPC1 2279/4885RAB9A 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.